PROVIDER PROFILE · NPI 1104969229

Firoozeh Parsa NezhadMD

Internal MedicineSan Francisco, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

186

Distinct HCPCS

Medicare payment

$11K

Peer benchmark

Total Medicare services vs. 10,499 Internal Medicine providers in CA — below median (cohort median 531).

PRESCRIBING · PART D · 2024

Total Rx claims

3,806

Beneficiaries

—

Total drug cost

$151K

Distinct drugs

Brand share

20.5%

Top prescribed drugs

Gabapentin388 claims

Amlodipine Besylate305 claims

Metformin Hcl168 claims

Baclofen168 claims

Atorvastatin Calcium146 claims

QUALITY · MIPS · 2024

Final MIPS score

88.2

Quality

61.1

Cost

83.7

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

0.56%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

CCN 050228

Hospital

CCN 050668

Hospital

CCN 555929

Nursing home

REFERRAL NETWORK

Where Firoozeh Parsa Nezhad's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CITY & COUNTY OF SAN FRANCISCO	25	754
CITY & COUNTY OF SAN FRANCISCO	19	128
CITY & COUNTY OF SAN FRANCISCO	14	124

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
CITY & COUNTY OF SAN FRANCISCO	29	966
CITY & COUNTY OF SAN FRANCISCO	22	170
CITY & COUNTY OF SAN FRANCISCO	19	183

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history